专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

81. 发明申请

WO00041707A2 USE OF LACTOBACILLUS SALIVARIUS 审中-公开
标题翻译：乳酸杆菌的使用
公开(公告)号：WO00041707A2
公开(公告)日：2000-07-20
申请号：PCT/IE2000/000007
申请日：2000-01-17
IPC分类号： A23L1/30 , A23C9/123 , A61K9/14 , A61K9/20 , A61K9/48 , A61K39/00 , A61K47/02 , A61K47/04 , A61K47/06 , A61K47/08 , A61K47/18 , A61K47/26 , A61K47/42 , A61K47/44 , A61K47/46 , A61P1/00 , A61P1/04 , A61P1/12 , A61P19/02 , A61P29/00 , A61P31/04 , A61P31/12 , A61P35/00 , A61P37/04 , A61P37/06 , A61P43/00 , C12N1/20 , C12R1/01 , C12R1/225 , A61K35/74
CPC分类号： C12R1/01 , A23C9/1234 , A23L33/135 , A23V2002/00 , A23Y2220/77 , A61K39/09 , A61K2039/52 , A61K2039/542 , C12N1/20 , Y10S435/822 , Y10S435/853 , A23V2200/3204 , A23V2200/324
摘要： Lactobacillus salivarius is useful in the prophylaxis or treatment of undesirable inflammatory activity, especially gastrointestinal inflammatory activity such as inflammatory bowel disease or irritable bowel syndrome. The inflammatory activity may also be due to cancer. The Lactobacillus salivarius is of human origin isolated from resected and washed human gastrointestinal tract. One such strain is UCC 118 described in WO-A-9835014.
摘要翻译：唾液乳杆菌可用于预防或治疗不良的炎性活动，特别是胃肠道炎症活动，如炎性肠病或肠易激综合征。炎性活动也可能是由于癌症。唾液乳杆菌是从切除和洗涤的人类胃肠道分离的人源。一种这样的菌株是在WO-A-9835014中描述的UCC 118。

82. 发明申请

WO1998022082A1 SPHINGOMYELINASE COMPOSITIONS AND USE THEREOF 审中-公开
标题翻译：弹力蛋白酶组合物及其用途
公开(公告)号：WO1998022082A1
公开(公告)日：1998-05-28
申请号：PCT/IT1997000278
申请日：1997-11-14
申请人： CAVALIERE, widow VESELY, Renata, Maria, Anna , DE SIMONE, Claudio
IPC分类号： A61K07/48
CPC分类号： A61K8/66 , A61K38/465 , A61K2800/70 , A61Q19/00 , C12Y301/04012 , Y10S435/853 , Y10S435/854 , Y10S435/855 , Y10S435/856 , Y10S435/857 , Y10S435/885
摘要： The use of sphingomyelinase to increase the levels of skin and mucosal ceramides, as well as dermatological and cosmetic compositions containing same which are suitable for topical application are disclosed.
摘要翻译：公开了使用鞘磷脂酶增加皮肤和粘膜神经酰胺的水平，以及含有适合局部应用的皮肤病学和化妆品组合物。

83. 发明申请

WO1997029204A1 PROCESS FOR TREATING RESIDUAL SERUM IN THE CHEESE FABRICATION, ELIMINATING ITS CONTAMINATING POWER AND OBTAINING L-LACTIC ACID 审中-公开
标题翻译：治疗残留血清的方法，消除其污染电力和获得L-乳酸
公开(公告)号：WO1997029204A1
公开(公告)日：1997-08-14
申请号：PCT/ES1997000006
申请日：1997-01-13
申请人： FUERTES GONZALEZ, Juan , MOYA MORA, Angela Mª
IPC分类号： C12P07/56
CPC分类号： C12P7/56 , A23C21/026 , Y10S435/819 , Y10S435/853 , Y10S435/856
摘要： Process for treating residual serum in the fabrication of cheese, thereby eliminating its contaminating power and obtaining L-lactic acid, characterized in that it comprises initially a fermentor with temperature and pH regulation for seeding an inoculum; a second industrial fermentor connected to an alkali container through a metering pump actuated by a pH-meter and, finally, the process gives successively passage to the fluid coming from the industrial fermentor through a press filter, through a hollow fiber microfilter and through ion exchange resin columns. The resulting final product has a pH lower than 2, free of nitrites and toxic substances; lactic acid with a high content of isomer l is obtained.
摘要翻译：用于在制造干酪中处理残留血清的方法，从而消除其污染能力并获得L-乳酸，其特征在于其最初包括温度和pH调节用于接种接种物的发酵罐; 通过由pH计驱动的计量泵连接到碱性容器的第二工业发酵罐，最后，该方法通过压滤机，通过中空纤维微过滤器和通过离子交换连续通过来自工业发酵罐的流体树脂柱。所得最终产品的pH值低于2，不含亚硝酸盐和有毒物质; 获得具有高含量异构体1的乳酸。

84. 发明申请

WO1996038159A1 MICRO-ENCAPSULATED LACTOBACILLI FOR MEDICAL APPLICATIONS 审中-公开
标题翻译：用于医疗应用的MICRO-ENCAPSULATED LACTOBACILLI
公开(公告)号：WO1996038159A1
公开(公告)日：1996-12-05
申请号：PCT/US1996008260
申请日：1996-05-31
申请人： LAFOR LABORATORIES LIMITED
发明人： LAFOR LABORATORIES LIMITED , FORD, Larry, C.
IPC分类号： A61K35/74
CPC分类号： A61K35/747 , A61K9/0034 , A61K9/1635 , A61K9/1652 , A61K9/5026 , A61K9/5031 , Y10S424/15 , Y10S435/853 , Y10S435/854 , Y10S514/967
摘要： Micro-encapsulated lactobacilli bacteria are orally administered to mammals, including humans, to treat or prevent antibiotic associated or other chronic or acute diarrhea. Micro-encapsulated lactobacilli bacteria are topically administered to the skin to treat or prevent recurrent skin infections, and are administered intra-vaginally to treat or prevent vaginal yeast infections.
摘要翻译：对包括人在内的哺乳动物口服施用微囊化的乳杆菌，以治疗或预防抗生素相关或其它慢性或急性腹泻。将微囊化的乳杆菌细菌局部施用于皮肤以治疗或预防复发性皮肤感染，并且经阴道内给药以治疗或预防阴道酵母菌感染。

85. 发明申请

WO1990000613A1 PROCESS FOR PREPARING OPTICALLY ACTIVE 2-HYDROXY-4-PHENYL-3-BUTENOIC ACID 审中-公开
标题翻译：制备光学活性的2-羟基-4-苯基-3-丁酮酸的方法
公开(公告)号：WO1990000613A1
公开(公告)日：1990-01-25
申请号：PCT/JP1989000698
申请日：1989-07-11
申请人： DAICEL CHEMICAL INDUSTRIES, LTD. , MATSUYAMA, Akinobu , TAKASE, Ichiro , UEDA, Yoichiro , KOBAYASHI, Yoshinori
发明人： DAICEL CHEMICAL INDUSTRIES, LTD.
IPC分类号： C12P07/42
CPC分类号： C12P7/42 , Y10S435/822 , Y10S435/824 , Y10S435/827 , Y10S435/83 , Y10S435/836 , Y10S435/84 , Y10S435/843 , Y10S435/85 , Y10S435/852 , Y10S435/853 , Y10S435/857 , Y10S435/873 , Y10S435/874 , Y10S435/885 , Y10S435/911 , Y10S435/921 , Y10S435/93
摘要： The invention relates to a process for preparing optically active 2-hydroxy-4-phenyl-3-butenoic acid, which comprises treating 2-oxo-4-phenyl-3-butenoic acid with an optionally treated microorganism capable of asymmetrically reducing said acid to (R)-2-hydroxy-4-phenyl-3-butenoic acid or (S)-2-hydroxy-4-phenyl-3-butenoic acid.

86. 发明申请

WO1986002837A1 A METHOD OF BINDING MICROFLORA AND PREPARATIONS THEREFOR 审中-公开
标题翻译：一种结合微血管的方法及其制备方法
公开(公告)号：WO1986002837A1
公开(公告)日：1986-05-22
申请号：PCT/SE1985000431
申请日：1985-11-05
申请人： CHEMICAL DYNAMICS SWEDEN AB , CONWAY, Patricia , KJELLEBERG, Staffan
发明人： CHEMICAL DYNAMICS SWEDEN AB
IPC分类号： A61K35/74
CPC分类号： C12P21/00 , A61K35/74 , C12P1/04 , C12R1/225 , Y10S435/853
摘要： The adhesion of non-pathogenic bacteria to the stomach and intestines of humans and animals is increased by the administration of the bacteria in the presence of a protein, designated adhesive promoting protein, which can be produced by cultivating lactic acid bacteria in a medium with the addition of forms of sugar of enhanced concentration. A preparation to increase said adhesion contains non-pathogenic bacteria cultivated in the manner described above, together with adhesive promoting protein.
摘要翻译：通过在称为粘附促进蛋白质的蛋白质的存在下施用细菌来增加非致病菌对人和动物的胃和肠的粘附，所述蛋白质可以通过在培养基中培养乳酸菌产生，增加浓度增加的糖形式。增加所述粘附性的制剂包含以上述方式培养的非致病细菌以及粘合促进蛋白质。

87. 发明申请

WO1985004901A1 MICROBIAL CO-CULTURE PRODUCTION OF PROPIONIC ACID 审中-公开
标题翻译：微生物共培养生产丙酸
公开(公告)号：WO1985004901A1
公开(公告)日：1985-11-07
申请号：PCT/US1985000566
申请日：1985-04-04
申请人： IGI BIOTECHNOLOGY, INC.
发明人： IGI BIOTECHNOLOGY, INC. , MAYS, Thomas, D. , FORNILI, Pamela, N.
IPC分类号： C12P39/00
CPC分类号： C12R1/225 , A21D2/145 , C12P7/52 , C12P7/54 , C12P7/56 , C12P39/00 , Y10S435/801 , Y10S435/822 , Y10S435/853 , Y10S435/885
摘要： The cultivation of proprietary and genetically altered strains of Lactobacillus casei subspecies rhamnosus in the presence of Veilonella criceti in a medium containing a fermentable carbohydrate results in the production of propionate, acetate, carbon dioxide and hydrogen. In the absence of either strain, carbohydrates are generally not fermented to propionate. Under optimum fermentation conditions lactate, the major product of carbohydrate metabolism of L. casei, is rapidly metabolized to propionate, acetate, carbon dioxide and hydrogen by V. criceti and is present in the culture medium at a concentration less than 0.5 milligrams per milliliter. The yield of propionate produced is approximately 1.4 moles propionate per mole of fermentable monosaccharide or 2.8 mole per moles of fermentable disaccharide utilized. In addition to the propionate fermentation, lactate can be accumulated by blocking its conversion to propionate by the adjustment of the pH, temperature or degree of aeration of the fermentation medium. Thus a mixture of propionate, acetate and lactate can be efficiently produced from fermentable carbohydrates by the co-cultivation of these bacterial strains.
摘要翻译：在含有可发酵碳水化合物的培养基中，在马鞭草菌存在下培育专有和遗传改变的干酪乳杆菌亚种鼠李糖杆菌菌株导致丙酸盐，乙酸盐，二氧化碳和氢气的产生。在没有任何应变的情况下，碳水化合物通常不会发酵成丙酸盐。在最佳发酵条件下，乳酸盐是酪蛋白的碳水化合物代谢的主要产物，被五叶草快速代谢成丙酸盐，乙酸盐，二氧化碳和氢气，并以浓度小于0.5毫克/毫升的浓度存在于培养基中。产生的丙酸酯的产量为每摩尔可发酵单糖约1.4摩尔丙酸酯或每摩尔可利用的可发酵二糖2.8摩尔。除了丙酸发酵之外，通过调节发酵培养基的pH，温度或通气程度，可以通过阻断乳酸转化成丙酸来积累乳酸。因此，通过这些细菌菌株的共同培养，可以通过可发酵的碳水化合物有效地产生丙酸盐，乙酸盐和乳酸盐的混合物。

88. 发明申请

WO2006110088A1 SELECTION AND USE OF LACTIC ACID BACTERIA FOR REDUCING INFLAMMATION IN MAMMALS 审中-公开
标题翻译：选择和使用乳酸菌来减少乳腺炎
公开(公告)号：WO2006110088A1
公开(公告)日：2006-10-19
申请号：PCT/SE2006/000434
申请日：2006-04-12
申请人： BIOGAIA AB
发明人： CONNOLLY, Eamonn
IPC分类号： A61K35/74 , C12N1/20 , A61P1/00 , A61P37/06
CPC分类号： A61K38/164 , A61K2035/11 , C12R1/225 , Y02A50/473 , Y10S435/853
摘要： Strains of lactic acid bacteria selected for their capability of reducing inflammation, such as intestinal bowel disease, a method of selecting such strains, and products containing such strains.
摘要翻译：选择用于减轻炎症的能力的乳酸菌菌株，例如肠道疾病，选择这种菌株的方法，以及含有这些菌株的产品。

89. 发明申请

WO2005060708A3 CANINE PROBIOTIC LACTOBACILLI 审中-公开
标题翻译：犬科动物乳杆菌
公开(公告)号：WO2005060708A3
公开(公告)日：2005-09-22
申请号：PCT/US2004043069
申请日：2004-12-17
申请人： IAMS COMPANY , ALIMENTARY HEALTH LTD , BOILEAU THOMAS WILLIAM-MAXWELL , CEDDIA MICHAEL ANTHONY , COLLINS JOHN KEVIN , DAVENPORT GARY MITCHELL , KIELY BARRY PIUS , O'MAHONY LIAM DIARMUID , SUNVOLD GREGORY DEAN , TETRICK MARK ALAN , VICKERS ROBERT JASON
发明人： BOILEAU THOMAS WILLIAM-MAXWELL , CEDDIA MICHAEL ANTHONY , COLLINS JOHN KEVIN , DAVENPORT GARY MITCHELL , KIELY BARRY PIUS , O'MAHONY LIAM DIARMUID , SUNVOLD GREGORY DEAN , TETRICK MARK ALAN , VICKERS ROBERT JASON
IPC分类号： A01N63/00 , A23K1/00 , A23K1/18 , A23L1/30 , A61K45/00 , C12N1/20 , C12R1/225
CPC分类号： C12N1/20 , A23K10/18 , A23K50/40 , A23L33/135 , A23Y2220/75 , A23Y2300/00 , A61K35/747 , C12R1/225 , Y10S426/805 , Y10S435/853
摘要： According to the invention there is provided a strain of lactic acid bacteria of the genus Lactobacilli obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Lactobacilli of the present invention are also provided.
摘要翻译：根据本发明，提供了通过从动物中具有益生菌活性的切除和洗涤的犬胃肠道分离获得的乳杆菌属乳酸菌菌株。还提供了使用方法和包含本发明的乳杆菌的组合物。

90. 发明申请

WO2004052462A1 COMPOSITION COMPRENANT DES LACTOBACILLUS OU DES BIFIDOBACTERIUM ET SON UTILISATION 审中-公开
标题翻译：包含乳酸杆菌或双歧杆菌的组合物及其用途
公开(公告)号：WO2004052462A1
公开(公告)日：2004-06-24
申请号：PCT/FR2003/003589
申请日：2003-12-04
申请人： RHODIA CHIMIE , LEYER, Grégory , DENNIN, Véronique , NUTTEN, Sophie , POT, Bruno , MERCENIER, Annick
发明人： LEYER, Grégory , DENNIN, Véronique , NUTTEN, Sophie , POT, Bruno , MERCENIER, Annick
IPC分类号： A61P37/02
CPC分类号： C12R1/225 , A23L33/135 , A23Y2220/00 , A23Y2220/67 , A23Y2300/49 , A61K35/742 , A61K35/745 , A61K35/747 , C12N1/20 , C12R1/01 , C12R1/23 , C12R1/25 , Y10S435/822 , Y10S435/853 , Y10S435/854 , Y10S435/857
摘要： La présente invention a pour objet une composition de bactéries ayant des propriétés d'immunomodulation qui comprend au moins une souche sélectionnée parmi le groupe constitué par Lactobacillus acidophilus PTA-4797, Lactobacillus plantarum PTA-4799, Lactobacillus salivarius PTA-4800, Lactobacillus paracasei PTA-4798, Bifidobacterium bifidum PTA-4801, Bifidobacterium lactis PTA-4802 et Bifidobacterium lactis PTA-5658.L'invention a aussi pour autre objet un procédé pour conférer ô un milieu des propriétés d'immunomodulation.
摘要翻译：本发明涉及具有免疫调节特性的细菌组合物，其包含选自嗜酸乳杆菌PTA-4797，植物乳杆菌PTA-4799，唾液乳杆菌PTA-4800，副干酪乳杆菌PTA-4798，双歧双歧杆菌PTA-4801，乳酸双歧杆菌 PTA-4802和乳酸双歧杆菌PTA-5658。本发明还涉及赋予环境免疫调节性质的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式